0
$0.00

Sermorelin 10mg

Customer Review 0
Rated 5 out of 5

$79.99

Researched Benefits:

  • Selective GHRHR agonist for investigating pulsatile somatotroph signaling and activation
  • Facilitates analysis of pituitary-dependent growth hormone secretion and release pathways
  • Supports research on cAMP-mediated transcription of growth hormone gene expression
  • Enables evaluation of somatostatin-antagonistic effects within controlled hypothalamic cell models
Share it :
Payment-Icon.png
International Shipment

Your orders are shipped seamlessly between countries

30 Days Warranty

You have the right to return your orders within 30 days.

Secure Payment

Your payments are secure with our private security network.

Description

Sermorelin 10mg is a synthetic peptide composed of the first 29 amino acids of Growth Hormone-Releasing Hormone (GHRH). Known for its potential to stimulate the body’s natural production of growth hormone, Sermorelin has become a focal point in studies exploring muscle growth, recovery, and overall metabolic function. Our Sermorelin is meticulously synthesized to ensure top-tier purity and reliability for advanced research projects.

Key Features:

  • Manufactured under stringent industry standards for consistent quality
  • Undergoes comprehensive quality control checks for utmost purity
  • Supplied in a lyophilized format to preserve stability and efficacy during storage

Applications:

  • Investigating the mechanisms of growth hormone release
  • Studying the impact on muscle growth, recovery, and tissue repair
  • Exploring potential effects on age-related hormone decline
  • Evaluating therapeutic avenues in regenerative and longevity research

 

Specifications and Documentation

 

Material Safety Data Sheet (MSDS): Coming Soon.

Handling and Storage Instructions: Coming Soon.

 

Sermorelin 10mg stands as a crucial component for researchers focusing on growth hormone pathways and potential regenerative applications, offering substantial insights for both scientific and clinical explorations.

0